Using automated spectral-domain optical coherence tomography, researchers found the presence of subretinal fluid (SRF) in individuals with diabetic macular edema (DME) is associated with lower baseline best-corrected visual acuity. The findings of this retrospective study suggest automated quantification of intraretinal fluid and SRF may be an objective approach to assess DME treatment.
Through GoMo Health’s partnership with the Center for Health Technology and Innovation (CHTI) at the American Heart Association (AHA), GoMo, in collaboration with the AHA, has launched the telehealth care coordination solution, known as Concierge Care, a behaviorally-based, patient-centric care solution that can lead to measurable and sustainable population health, said Patrick Dunn, program director of CHTI at the AHA, and Bob Gold, chief executive officer of GoMo Health.
Laboratories cannot keep up with the demand for coronavirus disease 2019 (COVID-19) testing results; job losses in Texas have led to many losing their insurance; a new California poll shows that Latinos worry most about finances and getting sick from COVID-19.
Through the partnership, Humana and Heal will expand the startup’s current markets to include Chicago, Charlotte, Houston and others that are part of Bold Goal, a multi-year effort to improve overall health of communities by addressing both medical needs and working with partners to address social determinants of health, such as food insecurity.
FDA increased oversight of antibody testing on May 5, requiring them to meet standards of other molecular tests.
HIV-positive individuals with end-stage kidney disease may now have a larger pool of kidneys available to them, with recent study results from the National Institutes of Health (NIH) showing that kidneys from HIV-positive deceased donors can be used in addition to those from HIV-negative donors.
When it comes to ease of use, ability to self-inject, and confidence in using an erenumab-prefilled disposable autoinjector, individuals with migraine consistently endorsed the preventive treatment, according to study results published in Patient Preference and Adherence.
Amid the coronavirus disease 2019 pandemic in Italy, a significant number of patients with epilepsy reported difficulties managing their condition, especially those who reported greater use of antiseizure medications for chronic therapy and poor sleep quality, according to study findings.
The race for a coronavirus disease 2019 (COVID-19) vaccine is one of the most urgent public health challenges, with multiple vaccine candidates entering phase 3 trials and case counts around the world steadily climbing. MJH Life Sciences™ will host a free webinar with the top minds in infectious disease, virology, and vaccinology to discuss the latest trial information on vaccines.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from a retrospective cohort study published in Annals of Internal Medicine.
Compared with digital mammography, digital breast tomosynthesis, also called 3-dimensional (3-D) mammography, has been proven superior at effectively detecting breast cancer and leading to fewer recall visits, but more information is needed for how subgroups of women with different breast densities benefit from the screening method, especially those classified as having extremely dense breast tissue.
Data from DAPA-CKD show that the trial met all its primary and secondary end points for patients with chronic kidney disease, with and without type 2 diabetes. The announcement comes after a data monitoring committee halted the trial in March 2020 when it found the evidence of efficacy was overwhelming.
A meeting at the White House with top pharmaceutical executives has been cancelled after the Trump administration’s executive orders signed this past Friday on the topic drew criticism from the drug industry; Kodak has won a $765 million US government loan to assist in expediting domestic production of drugs to treat several medical conditions and reduce US reliance on foreign supplies; more than a third of patients with mild illness from coronavirus disease 2019 (COVID-19) reported related symptoms that lasted for 2 to 3 weeks after testing positive.
Individuals who had experienced a concussion were found to be at a greater risk of Parkinson disease, mood and anxiety disorders (MADs), dementia, and hyperactivity disorder, with concussed women indicated as a notable at-risk population for MADs, according to study findings published today.
A comprehensive review of all safety-related label modifications of vaccines approved by the FDA between January 1996 and December 2015 found that vaccines are “remarkably safe” and confirmed population vaccination as a major public health strategy.
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology.
Researchers interviewed US specialists in an effort to see how conscious and unconscious thoughts about race and gender contributed to an unequal allocation of various treatments for heart failure.
In beginning the first phase 3 clinical trial to examine a vaccine candidate for the coronavirus disease 2019 (COVID-19), Moderna Inc announced that the Trump administration increased funding to expand the trial to 30,000 US participants; employers have considered and some have made it a requirement for employees to sign a waiver to not sue the organization if they are infected by COVID-19 or suffered any injury while working; study finds 1 flu shot can reduce the risk for Alzheimer disease by 17% and 1 pneumonia vaccine before age 75 can reduce the risk by 25%.
Alemtuzumab did not appear to negatively impact pregnancy outcomes in women who took the therapy for relapsing-remitting multiple sclerosis prior to becoming pregnant.
Having health insurance, a higher level of education, and more money were associated with a greater likelihood of caregivers disclosing their HIV status in the community, either positive or negative, while being male and living in a rural location indicated a lesser likelihood, reports AIDS Research and Therapy.
Assessing the value of novel therapies has been challenging and controversial using existing methods, pointing to the need for continued exploration of new approaches.
A study looking at the ways in which different countries handle appraisal and reimbursement processes for rare disease treatments (RDTs) revealed that implementing supplemental processes can aid in patient and physician decision making.
Deepak L. Bhatt, MD, MPH, of Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, presented the latest round of data from REDUCE-IT at the American Society of Preventive Cardiology Virtual Summit 2020 this morning
In the last 3 months of life, health care costs were significantly lower for patients receiving multidisciplinary collaborative care than for patients receiving specialized care or nonspecialized care. The differences in costs were primarily driven by differences in hospitalizations and emergency department visits.
In children with inflammatory rheumatic diseases, tocilizumab can cause serious adverse events (AEs), with children who were younger at disease onset and at time of tocilizumab initiation especially affected.
Just when renal replacement therapy should start after acute kidney injury has been debated.
The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices.
The therapy, to be sold as Tecartus, will be used to treat adult patients with mantle cell lymphoma who have relapsed or not responded to other treatments.
IQVIA, a health information technology and clinical research company, recently announced a new collaboration with JDRF, the world’s largest nonprofit funder of type 1 diabetes (T1D) research. Together, the companies plan to develop a real-world research platform to facilitate evidence generation for T1D via non-identified patient-level data and analytics.